Suppr超能文献

120瓦铥:钇铝石榴石前列腺蒸汽核化术与钬激光前列腺剜除术治疗良性前列腺增生的疗效及安全性比较

Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.

作者信息

Hong Kai, Liu Yu-Qing, Lu Jian, Xiao Chun-Lei, Huang Yi, Ma Lu-Lin

机构信息

Department of Urology, Peking University Third Hospital, Beijing 100191, China.

出版信息

Chin Med J (Engl). 2015 Apr 5;128(7):884-9. doi: 10.4103/0366-6999.154282.

Abstract

BACKGROUND

This study compared the efficacy and safety between 120-W thulium:yttrium-aluminum-garnet (Tm:YAG) vapoenucleation of prostates (ThuVEP) and holmium laser enucleation of prostates (HoLEP) for patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

METHODS

A retrospective analysis of 88 consecutive patients with symptomatic BPH was carried out, who underwent either 120-W ThuVEP or HoLEP nonrandomly. Patient demographics and peri-operative and 12-month follow-up data were analyzed with the International Prostate Symptom Score (IPSS), quality of life (QoL) score, maximum flow rate (Qmax), postvoid residual urine volume (PVR), and rates of peri-operative and late complications.

RESULTS

The patients in each group showed no significant difference in preoperative parameters. Compared with the HoLEP group, patients in the 120-W ThuVEP group required significantly shorter time for laser enucleation (58.3 ± 12.8 min vs. 70.5 ± 22.3 min, P = 0.003), and resulted in a significant superiority in laser efficiency (resected prostate weight/laser enucleation time) for 120-W Tm:YAG laser compared to holmium:YAG laser (0.69 ± 0.18 vs. 0.61 ± 0.19, P = 0.048). During 1, 6, and 12 months of follow-ups, the procedures did not demonstrate a significant difference in IPSS, QoL score, Qmax, or PVR (P > 0.05). Mean peri-operative decrease of hemoglobin in the HoLEP group was similar to the ThuVEP group (17.1 ± 12.0 g/L vs. 15.2 ± 10.1 g/L, P = 0.415). Early and late incidences of complications were low and did not differ significantly between the two groups of 120-W ThuVEP and HoLEP patients (P > 0.05).

CONCLUSIONS

120-W ThuVEP and HoLEP are potent, safe and efficient modalities of minimally invasive surgeries for patients with LUTS due to BPH. Compared with HoLEP, 120-W ThuVEP offers advantages of reduction of laser enucleation time and improvement of laser efficiency.

摘要

背景

本研究比较了120瓦掺铥钇铝石榴石(Tm:YAG)前列腺汽化剜除术(ThuVEP)与钬激光前列腺剜除术(HoLEP)治疗良性前列腺增生(BPH)所致下尿路症状(LUTS)患者的疗效和安全性。

方法

对88例有症状的BPH患者进行回顾性分析,这些患者非随机接受了120瓦ThuVEP或HoLEP治疗。采用国际前列腺症状评分(IPSS)、生活质量(QoL)评分、最大尿流率(Qmax)、残余尿量(PVR)以及围手术期和晚期并发症发生率对患者的人口统计学数据、围手术期数据和12个月的随访数据进行分析。

结果

每组患者术前参数无显著差异。与HoLEP组相比,120瓦ThuVEP组患者的激光剜除时间显著缩短(58.3±12.8分钟对70.5±22.3分钟,P = 0.003),并且120瓦Tm:YAG激光的激光效率(切除前列腺重量/激光剜除时间)显著优于钬激光(0.69±0.18对0.61±0.19,P = 0.048)。在1、6和12个月的随访期间,两种手术在IPSS、QoL评分、Qmax或PVR方面无显著差异(P>0.05)。HoLEP组围手术期血红蛋白平均下降幅度与ThuVEP组相似(17.1±12.0克/升对15.2±10.1克/升,P = 0.415)。两组120瓦ThuVEP和HoLEP患者的早期和晚期并发症发生率均较低,且无显著差异(P>0.05)。

结论

120瓦ThuVEP和HoLEP是治疗BPH所致LUTS患者的有效、安全且高效的微创手术方式。与HoLEP相比,120瓦ThuVEP具有缩短激光剜除时间和提高激光效率的优势。

相似文献

引用本文的文献

3
Reasons to go for thulium-based anatomical endoscopic enucleation of the prostate.行钬激光解剖性前列腺剜除术的理由。
World J Urol. 2021 Jul;39(7):2363-2374. doi: 10.1007/s00345-021-03704-7. Epub 2021 May 4.
7
Our clinic's first experience with HoLEP.我们诊所首次使用钬激光前列腺剜除术(HoLEP)的经历。
North Clin Istanb. 2019 Oct 25;6(4):355-360. doi: 10.14744/nci.2019.24855. eCollection 2019.

本文引用的文献

2
Long-term outcome following Thulium VapoEnucleation of the prostate.前列腺铥蒸汽剜除术的长期疗效
World J Urol. 2014 Dec;32(6):1551-8. doi: 10.1007/s00345-014-1260-2. Epub 2014 Feb 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验